Navigation Links
AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting

king a Triple-DAA Regimen for 12 Weeks
Poster #1096
November 3rd, 8:00AM ET; Poster Hall
This study presents medication adherence data based on electronic compilation of drug dosing history among 327 patients receiving the investigational triple-DAA regimen plus ribavirin for 8, 12 or 24 weeks.
  • Health-Related Quality of Life (HRQoL), Health State, Function and Wellbeing of Chronic HCV Patients Treated with Interferon-Free, Oral DAA Regimens: Patient Reported Outcome (PRO) Results from the AVIATOR Study
    Poster #1113
    November 3rd, 8:00AM ET; Poster Hall
    This intent-to-treat analysis from the phase IIb AVIATOR study includes patient reported outcomes (PRO) in patients receiving 12-week, ribavirin-containing investigational triple-DAA regimen.
  • Safety of Ribavirin-containing Regimens of ABT-450/r, ABT-333, and ABT-267 for the Treatment of HCV Genotype 1 Infection and Efficacy in Subjects with Ribavirin Dose Reductions
    Poster #1118
    November 3rd, 8:00AM ET; Poster Hall
    This study examined the safety of a ribavirin-containing, investigational triple-DAA, interferon-free regimen and the effects of ribavirin dose reductions on treatment response.
  • HCV RNA "Target Detected" after "Target Not Detected" During IFN-Free Treatment: Time to Worry or Not?
    Poster #1125
    November 3rd, 8:00AM ET; Poster Hall
    This study examined the frequency of TDANs (Target Detected After Not Detected) and the likelihood of subsequent virologic failure in subjects from the phase IIb AVIATOR study treated with ABT- 450/r plus ABT-267 plus ABT-333 plus ribavirin for 12 or 24 weeks in treatment naïve and null responders. 
  • Adherence to Interferon-containing Therapy Among Veteran Affairs Hepatitis C Patients
    Poster #1909
    November 5th, 8:00AM ET; Poster Hall
    Data from the United States Veterans Health Administration (VHA) Medical SAS Dataset (years 2008 to 2

  • SOURCE AbbVie Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
    2. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
    3. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
    4. AbbVie Declares Quarterly Dividend
    5. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
    6. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
    7. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
    8. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
    9. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
    10. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
    11. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
    Post Your Comments:
    (Date:10/8/2015)... and PITTSBURGH , Oct. 8, ... leading global pharmaceutical company, will host a conference call ... 5:00 pm ET to review the value to be ... PRGO ; TASE) through Mylan,s offer to acquire the ... presentation which outlines the compelling proposition for Perrigo shareholders. ...
    (Date:10/8/2015)... Oct. 8, 2015  Following months of investigation, Ross ... the nation alleging that the anticoagulant Xarelto,s recommended dosage doesn,t ... Philadelphia on behalf of a ... stroke because the drug didn,t work as the manufacturer suggested. ... other suits shortly on behalf of clients from across the ...
    (Date:10/8/2015)... a world leader in specialty chemicals, has announced that its ... New Mexico , has achieved ISO 15378:2011 certification for ... packets and other container-closure systems . ... site – the first in the United States ... only the Clariant manufacturing facility in Romorantin, France ...
    Breaking Medicine Technology:
    ... their babies , , SAN ANTONIO, ... Assure to its CitraNatal(R) family of prescription prenatal vitamins. CitraNatal ... increased nutrients for women and their babies. , ... for women who are pregnant or planning to become pregnant. ...
    ... Dec. 8 Halozyme Therapeutics, Inc.,(Nasdaq: HALO ... extracellular matrix, today announced that Roche has,dosed the first ... a,subcutaneous formulation using Enhanze Technology of a biologic directed ... payment under the,agreement. , ...
    Cached Medicine Technology:
    (Date:10/8/2015)... ... October 08, 2015 , ... The Clinical Data ... anniversary and reveal a new, patient-centered messaging campaign at its upcoming International Interchange, ... theme and campaign tagline, “Smarter Research to Unlock Cures,” supports numerous healthcare-driven presentations ...
    (Date:10/8/2015)... ... October 08, 2015 , ... In an increasingly complex healthcare ... to consistently deliver the highest quality of care, while exploring controversial issues impacting ... this year’s NASS meeting, the Spine division of Zimmer Biomet, a leading global ...
    (Date:10/8/2015)... ... 2015 , ... Three Maricopa Community Colleges will receive $7.8 ... made by the U.S. Department of Education. , GateWay, Glendale and Phoenix colleges ... grants enable Hispanic Serving Institutions (HSI) to expand and enhance their academic offerings, ...
    (Date:10/8/2015)... (PRWEB) , ... October 08, ... ... Sciences, a leading innovator in dental education, has officially launched Advanced Training ... for health care professionals. , Advanced Training Programs by VirtualU@WesternU offer an ...
    (Date:10/8/2015)... ... October 08, 2015 , ... ... the latest version of its proprietary tool which identifies serious adverse events (AEs) ... Events Explorer app, this release of RxSignal enhances the ability for managed care ...
    Breaking Medicine News(10 mins):
    ... in cells that keeps the human body cranking along. ... a clue that could lead to programming the ribosome ... ,In the March 23 issue of the journal ... and research assistant professor Artural Meskauskas describe how their ...
    ... India. A study in the US has found that children in ... in class. The effect persisted through the sixth grade. ... family income, and regardless of the quality of the day care ... the National Institute of Child Health and Human Development, recruited families ...
    ... the world, researchers are discovering that some foods and supplements ... modern// world’s deadliest killer- the ‘big C’. At the 233rd ... more than a dozen research papers on this topic will ... ,Black raspberries show promise for preventing cancer of the ...
    ... can efficiently seek out and kill cancer cells while ... the Nature's way of distinguishing one type of cell ... presented today (March 25) at the annual national meeting ... the body's natural antibodies and immune responses. "The killing ...
    ... an unlucky neighbor for Tripura, as the northeastern state of ... , Bird flu in Bangladesh has proved a fear ... Tripura, the state also imports chicks and eggs from Bangladesh. ... Welfare Preventive Medicine and the Animal Resource Development departments have ...
    ... most everything imagined in science fiction comes true. // ... without wires, today's science increasingly resembles yesterday's fiction. And ... ,For those of us at the AAAS ... by Jennifer French. She's not a scientist. She's a ...
    Cached Medicine News:
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: